Obexelimab marketing applications for the treatment of IgG4-RD expected to be submitted to the FDA in Q2 2026 and the EMA in H2 2026 based on the Phase 3 INDIGO trial results - - Topline results of ...

Ajay Nirula, M.D., Ph.D., will now also serve as president, in addition to his role as head of research and development-Catherine Bovenizer, ...

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875) (the “Company”), announces that ...

The widening war in Iran is now in its third week, and American consumers are already feeling the effects of the rising cost ...

Jeffrey Epstein used his money and influence in the world of elite private schools to assist friends and acquaintances.

Georgetown University aims to establish new academic initiatives in Athens, Greece, featuring graduate programs targeted ...

Global Banking & Finance Review® is pleased to announce that Shanghai Pudong Development Bank Co., Ltd has been named Best ...

Doctors and scientists are running for office, motivated by concerns over health policy, anti-science movements, and cuts to ...

Payer relations executives to know in 2026 are shaping managed care strategies at major health systems and advancing value-based payment models.

Lt. Gov. Sylvia Luke says she did not take the notorious paper bag of $35,000 in cash from a campaign donor looking to buy influence in state government. She did receive close to that amount in checks ...

In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to discuss the latest CNM-Au8® data submitted; Clene expects formal ...